Gad Soffer, Chief Operating Officer at Atara Biotherapeutics, Inc. (ATRA), sold 5,711 shares at $16.07 ($96K) on 2016-02-17, disclosed to the SEC on 2016-02-18.
Open-market sale of $96k ATRA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.07 | 1,928 | $31K | 32.3% |
| 2 | $17.13 | 3,783 | $65K | 67.7% |
| Total | $16.77 avg | 5,711 | $96K | 100% |
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |